| 2024-05-01 13:37 | CC:PHRM | Pharmather Holdings Ltd | 0.275 | News Release200 | Pharmather, Pharmadrug complete PD-001 clinical package |
| 2024-04-23 02:12 | CC:PHRM | Pharmather Holdings Ltd | 0.215 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-04-23 02:11 | CC:PHRM | Pharmather Holdings Ltd | 0.215 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-04-18 16:10 | CC:PHRM | Pharmather Holdings Ltd | 0.23 | News Release200 | Pharmather receives complete response for ketamine ANDA |
| 2024-04-16 14:03 | CC:PHRM | Pharmather Holdings Ltd | 0.21 | News Release200 | Pharmather hopes to submit ketamine responses this week |
| 2024-04-02 11:21 | CC:PHRM | Pharmather Holdings Ltd | 0.385 | News Release200 | Revive clinical study enrolls nearly 50% of sample |
| 2024-02-21 13:19 | CC:PHRM | Pharmather Holdings Ltd | 0.21 | News Release200 | Pharmather, Pharmadrug begin Sairiyo plan for PD-001 |
| 2024-02-14 13:15 | CC:PHRM | Pharmather Holdings Ltd | 0.225 | News Release200 | Pharmadrug unit to manufacture PD-001 for human studies |
| 2024-02-12 11:12 | CC:PHRM | Pharmather Holdings Ltd | 0.19 | News Release200 | Pharmather talks ketamine ANDA, possible deficiencies |
| 2024-01-10 11:21 | CC:PHRM | Pharmather Holdings Ltd | 0.225 | News Release200 | Pharmather expects FDA ketamine approval April 29, 2024 |
| 2023-10-30 19:15 | CC:PHRM | Pharmather Holdings Ltd | 0.135 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-10-30 19:15 | CC:PHRM | Pharmather Holdings Ltd | 0.135 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-28 18:20 | CC:PHRM | Pharmather Holdings Ltd | 0.14 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-09-27 10:36 | CC:PHRM | Pharmather Holdings Ltd | 0.15 | News Release200 | Pharmather's Ketarx drug application accepted by FDA |
| 2023-09-06 10:38 | CC:PHRM | Pharmather Holdings Ltd | 0.14 | News Release200 | Pharmather submits new drug application for Ketarx |
| 2023-07-18 10:06 | CC:PHRM | Pharmather Holdings Ltd | | News Release200 | Pharmather completes PharmaPatch research study |
| 2023-06-27 12:05 | CC:PHRM | Pharmather Holdings Ltd | 0.15 | News Release200 | Pharmather files presubmission facility correspondence |
| 2023-06-20 07:51 | CC:PHRM | Pharmather Holdings Ltd | 0.105 | News Release200 | Pharmather, Vitruvias to collaborate for Ketarx |
| 2023-06-12 09:36 | CC:PHRM | Pharmather Holdings Ltd | 0.095 | News Release200 | Pharmather hopes to receive Ketarx FDA OK in Q1 2024 |